Response Oncology (Response Oncology) EBIT per Share : $-4.16 (TTM As of Mar. 2002)

View and export this data going back to 1989. Start your Free Trial

What is Response Oncology EBIT per Share?

Response Oncology's EBIT per Share for the three months ended in Mar. 2002 was $-0.05. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2002 was $-4.16.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Response Oncology's EBIT per Share or its related term are showing as below:

ROIX's 3-Year EBIT Growth Rate is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 7.75
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Response Oncology's EBIT for the three months ended in Mar. 2002 was $-0.6 Mil.

Response Oncology EBIT per Share Historical Data

The historical data trend for Response Oncology's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Response Oncology EBIT per Share Chart

Response Oncology Annual Data

Trend

Dec92

Dec93

Dec94

Dec95

Dec96

Dec97

Dec98

Dec99

Dec00

Dec01

EBIT per Share

Get a 7-Day Free Trial

0.90

0.49

0.21

-1.42

-4.17

Response Oncology Quarterly Data
	Jun97	Sep97	Dec97	Mar98	Jun98	Sep98	Dec98	Mar99	Jun99	Sep99	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02
EBIT per Share	Get a 7-Day Free Trial															-0.07	-0.02	-0.01	-4.07	-0.05

Response Oncology EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Response Oncology's EBIT per Share for the fiscal year that ended in Dec. 2001 is calculated as

	EBIT per Share		(A: Dec. 2001 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-51.308	/	12.291
=	-4.17

Response Oncology's EBIT per Share for the quarter that ended in Mar. 2002 is calculated as

	EBIT per Share		(Q: Mar. 2002 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.607	/	12.280
=	-0.05

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2002 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.16

Response Oncology (GREY:ROIX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Response Oncology EBIT per Share Related Terms

Thank you for viewing the detailed overview of Response Oncology's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Response Oncology (Response Oncology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Response Oncology Inc (GREY:ROIX) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1775 Moriah Woods Boulevard, Memphis, TN, USA, 38117

Website

Response Oncology Inc provides cancer treatments and related services on an outpatient basis.

Response Oncology (Response Oncology) Headlines

No Headlines